OBJECTIVE: We sought to estimate the impact of corporate health-management and risk-reduction programs for The Dow Chemical Company by using a prospective return-on-investment (ROI) model. METHODS: The risk and expenditure estimates were derived from multiple regression analyses showing relationships between worker demographics, health risks, and medical expenditures. RESULTS: A "break-even" scenario would require Dow to reduce each of 10 population health risks by 0.17% points per year over the course of 10 years. More successful efforts at reducing health risks in the population would produce a more significant ROI for the company. CONCLUSIONS: Findings from this study were incorporated into other components of a business case for health and productivity management, and these supported continued investments in health improvement programs designed to achieve risk reduction and cost savings.
OBJECTIVE: We sought to estimate the impact of corporate health-management and risk-reduction programs for The Dow Chemical Company by using a prospective return-on-investment (ROI) model. METHODS: The risk and expenditure estimates were derived from multiple regression analyses showing relationships between worker demographics, health risks, and medical expenditures. RESULTS: A "break-even" scenario would require Dow to reduce each of 10 population health risks by 0.17% points per year over the course of 10 years. More successful efforts at reducing health risks in the population would produce a more significant ROI for the company. CONCLUSIONS: Findings from this study were incorporated into other components of a business case for health and productivity management, and these supported continued investments in health improvement programs designed to achieve risk reduction and cost savings.
Authors: Ron Z Goetzel; Kristin M Baker; Meghan E Short; Xiaofei Pei; Ronald J Ozminkowski; Shaohung Wang; Jennie D Bowen; Enid C Roemer; Beth A Craun; Karen J Tully; Catherine M Baase; David M DeJoy; Mark G Wilson Journal: J Occup Environ Med Date: 2009-02 Impact factor: 2.162
Authors: Carolina Barbosa; Jeremy W Bray; William N Dowd; Michael J Mills; Phyllis Moen; Brad Wipfli; Ryan Olson; Erin L Kelly Journal: J Occup Environ Med Date: 2015-09 Impact factor: 2.162
Authors: Luke Wolfenden; Sharni Goldman; Fiona G Stacey; Alice Grady; Melanie Kingsland; Christopher M Williams; John Wiggers; Andrew Milat; Chris Rissel; Adrian Bauman; Margaret M Farrell; France Légaré; Ali Ben Charif; Hervé Tchala Vignon Zomahoun; Rebecca K Hodder; Jannah Jones; Debbie Booth; Benjamin Parmenter; Tim Regan; Sze Lin Yoong Journal: Cochrane Database Syst Rev Date: 2018-11-14